Long-Term Assets: The sum of all assets classified as non-current.
COSCIENS Biopharma Inc. (T.CSC) Long-Term Assets data is not available.
| Income Statement Financials | |
-- |
|
-2.51M |
|
-- |
|
-- |
|
-- |
|
-3.20M |
|
-- |
|
-2.51M |
|
-2.51M |
|
-2.51M |
|
-2.51M |
|
-2.51M |
|
-2.51M |
|
-3.20M |
|
-2.80M |
|
3.18M |
|
3.18M |
|
-0.79 |
|
-0.79 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
|
Long-Term Assets |
-- |
32.87M |
|
-- |
|
-- |
|
-- |
|
25.87M |
|
7.00M |
|
7.00M |
|
7.00M |
|
3.18M |
|
| Cash Flow Statement Financials | |
-9.65M |
|
-0.91M |
|
-0.54M |
|
22.58M |
|
11.74M |
|
-10.84M |
|
-0.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.47 |
|
-- |
|
-- |
|
0.28 |
|
0.43 |
|
41.87% |
|
-156.64% |
|
-156.64% |
|
-- |
|
-122.66% |
|
-122.66% |
|
-10.55M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
0.49 |
|
0.92 |
|
97.40 |
|
-35.81% |
|
-35.81% |
|
-7.62% |
|
-25.84% |
|
2.20 |
|
-3.32 |
|
-3.04 |
|